Eastwoods Consulting
Notes from the East Woods

musings on opportunities in the life science marketplace 

   October 2011   
  
EC border

Greetings!

Don't lose your mind like the squirrels - be prepared for changes in your marketplace.  Please have a read and feel free to let me know what you think. 

Also if you missed some of our earlier Notes, you can view them all here.


Regards,

Paul Danis
Founder and Principal

Join Our Mailing List!
This Month's Features
- Squirrels, Hysteria and Markets
- Life Science Market Update
- About Eastwoods Consulting
Squirrels, Hysteria and Markets  

squirrel

The squirrels are all going crazy.  Their once-dependable fall staple of acorns is no where to be seen, and they are in a frenetic state.  The abundant supply of carbohydrates, fats and proteins has simply not shown up this year.  This hysteria is what some companies experience when they awaken to the fact that their most dependable and profitable market segment is no more.

 

Markets are not static - they evolve, grow, shrink, disappear, and are built. The challenge is to know when this may happen so you can be ready to take advantage of the new sustenance.  Here are a few things that you can do to be sure you don't end up like the squirrels.

  • Having a deep understanding of your customers' situations is the best starting point.  After all, they have the problem and the money (usually).  For instance, if you are selling 96-well screening thingamajigs and your customers have big backlogs, then there is an opportunity for you (or your competitors...)
  • What is everybody else doing?  I'm sure the squirrels quickly surmised that all their brethren were fighting them for the 3 acorns that fell on their acre.  If your competitors are fiercely throwing all kinds of effort (and VP's) at even small business opportunities, then something is afoul in your market.
  • The good news is that markets do not tend to vaporize; the problems that were being addressed often just shift to new solutions.  Similarly the squirrels are now all rushing to get sugar maple seeds stashed away.  Capillary sequencing, HPLC, and shrink-wrapped software are in the process of being supplanted by NGS, UHPLC, and SAS.  [next-generation sequencing, ultra-high pressure liquid chromatography, and software as a service, in case you were curious].  People still need to buy stuff, just not the old stuff.
  • The easiest way to get a sense of market reorganization is to look at some external factors.  If the squirrels had realized that last year's super-abundance would be followed by a lean year, they could have been better prepared (though this, of course, is beyond their walnut-sized brains).  Trade show attendance, funding agencies' programs, M&A activity, and capital raising are all good indicators of where the action is... and isn't.

So when your dependable sources of nutrition are disappearing, be sure you know where to find your next pile of revenue.  Like the trusty annual crop of acorns, things will change and you will need to adjust your diet.

 

 



Life Science Market Update

Index

May Value

Change 12mo.

12 mo. High

12 mo. Low

EC BioTool

552 

0%

730

551 

EC BigPharma

821 

3%

934

767

EC Biotech

705 

17%

814

602 



The Tools sector continues to be the weakest, down 24% since June.  The decrease in funding from government agencies is having an effect on the outlook here.  The only outstanding performer is Caliper, up 39% on the acquisition by Perkin Elmer. Big Pharma and Biotech are only down 10% and 12%, resp. since June, in line with the general market.  In Biotech declines led advances 4 to 1 with 5 companies down over 15% for the month.  In BigPharma, declines led advances 7 to 1, but most were in the minus 3-7% range. 

.

 
EC BioIndex
October 2011


EC BioIndex


---------------------
Many of the life science indices currently available are a mixture of various types of companies. In order to better assess the situation in the different segments, Eastwoods Consulting has created these price-weighted indices for the sectors of large pharmaceutical companies, biotech companies, and life science research tools companies.
  •   EC BioTools Index - A, ACCL, AFFX, BIO, BRKR, CALP, HBIO, HLCS, ILMN, LIFE, LMNX, PKI, QGEN, SIAL, TECH, TMO, WAT
  •   EC BigPharma Index - JNJ, PFE, GSK, NVS, SNY, LUN, ABT, LLY, AZN, WYE, BMY, NVO, BAX, TEVA, VRX.TO, ROG.VX
  •   EB Biotech Index - AMGN, BIIB, CEPH, GILD, BMRN, AMLN, IDXX, ITMN, SEPR, PDLI, CPHD, ALKS, REGN, VRTX, THRX, HGSI, SGMO, NKTR, SHPGY 
  •   Prices are taken at the close of each month.   
EC Border
 
About Eastwoods Consulting
Eastwoods Consulting

Translating Innovations into Profits for the Life Science Industrysm

Eastwoods Consulting helps life science companies grow their businesses.  Please visit our web site or contact us to learn more about how we help companies succeed in competitive markets.
 


Copyright © 2011, Eastwoods Consulting. This publication may be freely redistributed in full or in part as long as full attribution including our contact information and web address, are included.  Eastwoods is a registered servicemark of Eastwoods Consultng.